Purdue Pharma begins several days of hearings Wednesday to finalize a $7.4 billion bankruptcy restricting plan that no longer ...
OxyContin maker Purdue Pharma urged a bankruptcy judge on Wednesday to approve a restructuring plan that includes a $7.4 ...
The company and the once-prominent family behind the drug OxyContin agreed Thursday to increase their financial contribution to resolve mass opioid litigation. The Sacklers and Purdue Pharma boosted ...
On Monday, the Supreme Court will take on one of its highest-profile bankruptcy cases in recent memory: Whether or not to approve OxyContin-maker Purdue Pharma's controversial agreement that would ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. The attorneys general for eight holdout ...
OxyContin maker Purdue Pharma has reached a nationwide settlement Thursday over its role in the opioid crisis. The deal would require members of the Sackler family, who own the drugmaker, to pay as ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results